![](/img/cover-not-exists.png)
Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis
Alawi A. Alsheikh-Ali, Richard H. KarasVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/j.jacl.2009.02.005
File:
PDF, 172 KB
english, 2009